MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma.

Pettit, Cory; Webb, Amy; Walston, Steve; Chatterjee, Moumita; Chen, Wei; Frankel, Wendy; Croce, Carlo; Williams, Terence M

Pettit, Cory; Webb, Amy; Walston, Steve; Chatterjee, Moumita; Chen, Wei; Frankel, Wendy; Croce, Carlo; Williams, Terence M.

Afiliação

Pettit C; The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH 43210, USA.
Webb A; The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH 43210, USA.
Walston S; The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH 43210, USA.
Chatterjee M; The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH 43210, USA.
Chen W; The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH 43210, USA.
Frankel W; The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH 43210, USA.
Croce C; The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH 43210, USA.
Williams TM; The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, OH 43210, USA.

Oncotarget ; 9(48): 28951-28964, 2018 Jun 22.

Article em En | MEDLINE | ID: mdl-29988972